Ionis Pharmaceuticals (IONS) was given a new $110.00 price target by Canaccord Genuity Group Inc..
How The Ionis Pharmaceuticals (IONS) Story Is Shifting With New Targets And 2026 Catalysts [Yahoo! Finance]
Ionis to hold first quarter 2026 financial results webcast
Ionis Pharmaceuticals (IONS) was given a new $104.00 price target by Raymond James Financial, Inc..
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.